EVH - Evolent Health, Inc.
收市後：
| 前收市價 | 31.69 |
| 開市 | 31.83 |
| 買盤 | 31.53 x 900 |
| 賣出價 | 31.55 x 900 |
| 今日波幅 | 31.50 - 32.01 |
| 52 週波幅 | 21.83 - 39.78 |
| 成交量 | |
| 平均成交量 | 914,304 |
| 市值 | 3.567B |
| Beta 值 (5 年，每月) | 1.55 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.38 |
| 業績公佈日 | 2023年7月31日 - 2023年8月04日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 47.25 |
BenzingaEvolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s
Insider MonkeyHere’s Why Evolent Health (EVH) Declined in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
BenzingaThis Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'
Thursday after close, Evolent Health Inc (NYSE: EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. William Blair is positive on the acquisition and believes this is consistent with management's prior commentary that Evolent would consider strategic assets that fit under the specialty care man
BenzingaCentene Agrees To Divest Magellan Specialty Health To Evolent Health
Evolent Health Inc (NYSE: EVH) has agreed to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management organization owned by Centene Corporation (NYSE: CNC). The organization focuses on managing cost and quality in radiology, musculoskeletal, physical medicine, and genetics. Deal consideration includes $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance. The upfront consideration will be partly funded by
Insider MonkeyRay Dalio Stock Portfolio Q3 2022: Top 10 Small-Cap Stocks
In this article, we discuss the top 10 small-cap stocks from Ray Dalio’s Q3 2022 portfolio. If you want to see more stocks in this selection, check out Ray Dalio Stock Portfolio Q3 2022: Top 5 Small-Cap Stocks. According to Royce Investment Partners, although equity prices declined in the volatile market environment through the first […]
Insider MonkeyTop 10 Stock Picks of Joe Milano’s Greenhouse Funds
In this article, we examined Joe Milano’s portfolio management strategy and approach to investing in stocks. We also reviewed the top 10 stock picks of Joe Milano’s Greenhouse Funds. You can skip our detailed discussion about Joe Milano’s investment philosophy and portfolio management strategies and jump directly to the Top 5 Stock Picks of Joe […]
BenzingaEvolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal
View more earnings on EVHSee more from BenzingaOyster Point Outlines Restructuring Plan With Savings Of Up To $48M In 202389bio Posts Promising Pegozafermin Data For Severe HypertriglyceridemiaDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.